B

Bharat Parenterals Ltd

BPLPHARMA
Market snapshot · 2026-08-11 11:17 UTC

1,392.00

+₹12.00 (+0.87%)

MARKET CAP

₹959.36 Cr

STOCK P/E

52W HIGH

₹1,559.90

52W LOW

₹880.25

BOOK VALUE

₹795.60

EPS

₹-39.74

ROE

SECTOR

Health Care

DEBT/EQUITY

46.89

VOLUME

2,121

P/B RATIO

1.75x

PEG RATIO

Sector

Health Care

Themes

PharmaceuticalsAshish Kacholia Portfolio
D
Dividend
₹1,480.40₹1,336.19₹1,191.98₹1,047.76₹903.55VolumeDAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Bharat Parenterals Ltd is a pharmaceutical company, but its specific operating segments and revenue-driving products are not disclosed. No major recent development provides a clear catalyst for revenue growth or margin expansion. Financial data are unavailable, preventing assessment of ROE, leverage, or earnings quality beyond a reported stable margin trend. P/E is also unavailable, so valuation cannot be judged against sector multiples or growth; investor focus remains on disclosure quality and business visibility.

Valuation Metrics

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/S
Strongly Overvalued

5Y Average

1.88

Current

2.99

Overvalued

2.84

Undervalued

0.79

P/B
Strongly Undervalued

5Y Average

2.58

Current

1.76

Overvalued

2.97

Undervalued

2.20

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹56 CrJun 2026

Latest net profit

₹3.66 CrJun 2026

Latest EPS

₹5.31Jun 2026

Net margin

12.3%Jun 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q1 '26Q2 '26Q3 '26Q4 '26Q1 '270.0%5.0%10.0%15.0%20.0%0.00 Cr25 Cr50 Cr75 Cr100 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q1 '26Q2 '26Q3 '26Q4 '26Q1 '270.00 Cr25 Cr50 Cr75 Cr100 Cr₹0₹4₹8₹12₹16
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherNet Profit0.00 Cr15 Cr30 Cr45 Cr60 Cr

Latest reported period: Jun 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-200 Cr0.00 Cr200 Cr400 Cr600 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales +69.9159.8158.8065.6492.0664.4567.3480.2894.3741.7041.4156.5455.50
Expenses +58.4253.3852.0261.9177.0758.7958.9975.6879.1139.3637.9456.5148.67
Operating Profit11.496.436.783.7314.995.668.354.6015.262.343.470.036.83
OPM %16.44%10.75%11.53%5.68%16.28%8.78%12.40%5.73%16.17%5.61%8.38%0.05%12.31%
Other Income +2.863.462.403.243.904.603.792.261.624.212.284.441.05
Interest0.880.610.611.091.020.881.411.481.420.960.550.510.69
Depreciation1.511.611.671.611.611.751.861.822.062.172.102.042.26
Profit before tax11.967.676.904.2716.267.638.873.5613.403.423.101.924.93
Tax %25.67%27.51%26.52%28.10%25.09%28.05%26.61%35.96%25.37%20.18%38.06%28.65%25.96%
Net Profit +8.895.565.073.0712.185.496.502.2810.002.731.921.383.66
EPS in Rs15.399.558.715.2818.678.419.433.3114.513.962.792.005.31
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters +67.19%67.19%67.19%67.17%67.20%
FIIs +0.11%0.11%0.11%0.11%0.11%
DIIs +0.54%0.54%0.54%1.07%1.38%
Public +32.16%32.16%32.17%31.65%31.31%
Jun 2026
Promoters +
FIIs +
DIIs +
Public +

Events Timeline

Announcement under Regulation 30 (LODR)-Newspaper Publication

Aug 07, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Investor Presentation

Aug 05, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Change in Directorate

Aug 05, 2026PDFCompany Reports Open

Financial Results For The Quarter Ended On June 30, 2026

Aug 05, 2026PDFCompany Reports Open

Board Meeting Outcome for Outcome Of Board Meeting

Aug 05, 2026PDFCompany Reports Open